Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5-6
pubmed:dateCreated
2008-2-11
pubmed:abstractText
Oxaliplatin damages the DNA, leading to apoptosis. XPA, XPD, ERCC1 and XPG genes are involved in DNA repair, and single nucleotide polymorphisms (SNPs) in these genes can influence the efficacy of oxaliplatin. We examined SNPs in these genes and correlated the results with time to progression (TTP), overall survival and response to oxaliplatin in 42 advanced colorectal cancer patients (CRC) treated with first-line oxaliplatin/fluoropyrimidine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/DNA excision repair protein ERCC-5, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/ERCC1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/ERCC2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Endonucleases, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/XPA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Xeroderma Pigmentosum Group A..., http://linkedlifedata.com/resource/pubmed/chemical/Xeroderma Pigmentosum Group D..., http://linkedlifedata.com/resource/pubmed/chemical/capecitabine, http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
pubmed:status
MEDLINE
pubmed:issn
1423-0232
pubmed:author
pubmed:copyrightInfo
(c) 2008 S. Karger AG, Basel
pubmed:issnType
Electronic
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
364-70
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18204222-Adult, pubmed-meshheading:18204222-Aged, pubmed-meshheading:18204222-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18204222-Colorectal Neoplasms, pubmed-meshheading:18204222-DNA Repair, pubmed-meshheading:18204222-DNA-Binding Proteins, pubmed-meshheading:18204222-Deoxycytidine, pubmed-meshheading:18204222-Disease Progression, pubmed-meshheading:18204222-Endonucleases, pubmed-meshheading:18204222-Female, pubmed-meshheading:18204222-Fluorouracil, pubmed-meshheading:18204222-Humans, pubmed-meshheading:18204222-Male, pubmed-meshheading:18204222-Middle Aged, pubmed-meshheading:18204222-Nuclear Proteins, pubmed-meshheading:18204222-Organoplatinum Compounds, pubmed-meshheading:18204222-Polymorphism, Single Nucleotide, pubmed-meshheading:18204222-Survival Analysis, pubmed-meshheading:18204222-Transcription Factors, pubmed-meshheading:18204222-Xeroderma Pigmentosum Group A Protein, pubmed-meshheading:18204222-Xeroderma Pigmentosum Group D Protein
pubmed:year
2007
pubmed:articleTitle
Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
pubmed:affiliation
Department of Human Anatomy and Embryology, University of Barcelona School of Medicine, Barcelona, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't